Onco-Hu® Mouse Models for Cancer Immunotherapy Research Explained

Onco-Hu® models are a robust immuno-oncology platform for efficacy testing of novel immunotherapies targeting T cells and myeloid cells. The platform is based on NSG™ and NSG-SGM3 transgenic mice, dually engrafted with human CD34+ hematopoietic stem cells (HSCs) and clinically relevant PDX Live low passage tumors. Watch this video to learn more about Onco-Hu® mouse models.

watch now

Registration is Open